The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis
Sponsored by National University of Malaysia
About this trial
Last updated 2 years ago
Study ID
FF-2021-421
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex
Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis.
There are two hypotheses of this study:
1. Elonide nasal spray is same efficacy to Nasonex nasal spray.
2. Elonide nasal spray is more efficient to placebo.
What are the participation requirements?
Inclusion Criteria
- All adults patients 18 years and above
- Newly diagnosed mild, moderate to severe, intermittent and persistent allergic rhinitis
- Positive skin prick test or serum Immunoglobulin E
Exclusion Criteria
- Patients who have been on allergic rhinitis treatment
- Below 18 years old
- Patients diagnosed with asthma or immunodeficiency diseases
- Pregnancy
- Other concomitant rhinology disease
- Smokers
- Severe deviated nasal septum